Ambiq Micro, Inc. reported its financial results for the second quarter of 2025, showing a 13.6% sequential increase in net sales to $17.9 million.
The company expanded its Apollo5 System-on-Chip (SoC) family by introducing the Apollo510B wireless SoC for power-constrained edge AI applications.
Ambiq received Frost & Sullivan's 2025 Global Company of the Year Award for its excellence in Healthcare Semiconductor Solutions and successfully completed an upsized IPO.
Revenue Growth
Net sales increased by 13.6% sequentially to $17.9 million in the second quarter of 2025.
Product Expansion
Introduced Apollo510B wireless SoC for power-constrained edge AI applications, enhancing the Apollo5 product family.
Awards Recognition
Received the 2025 Global Company of the Year Award from Frost & Sullivan for leadership in Healthcare Semiconductor Solutions.
Strategic IPO
Successfully executed an upsized IPO, generating net proceeds of $97.2 million to support strategic initiatives.
- The 13.6% sequential revenue growth highlights the strong customer demand for Ambiq's technology platform.
- The strategic IPO and net proceeds will accelerate Ambiq's expansion into new markets and drive long-term profitable growth.
Ambiq's second quarter financial results demonstrate robust revenue growth, product innovation, and industry recognition. The company is well-positioned to capitalize on the growth of edge AI applications and drive future success in the semiconductor market.